4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-026142
VP and Chief Compliance Office gave up 1,280 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Herman James L VP and Chief Compliance Office | 2022-03-20 | Shares withheld for taxes | −1,280 | $2.74 | $3,507 | 40,721 | D |
| Derivatives | |||||||
| Herman James L VP and Chief Compliance Office | 2022-03-16 | Grant or award · Options (right to buy) | +6,000 | 6,000 | D | ||
Loading xslF345X03/doc4.xml…